Document Detail


Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong.
MedLine Citation:
PMID:  23151816     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Oral anticoagulation medications such as warfarin reduce the risk of stroke in atrial fibrillation (AF) but have been underutilized. This study aimed to investigate physicians' perceptions of stroke prevention management and patients' knowledge of AF and warfarin therapy in Hong Kong (HK). HYPOTHESIS: Both physician and patient's knowledge on warfarin use were the barriers for stroke prevention in patients with atrial fibrillation in Hong Kong. METHODS: This prospective survey-based study was conducted between February 2011 and April 2011 to assess physicians' perceptions of stroke prevention management, patients' knowledge of AF, and patients' knowledge of warfarin therapy. The results were scored and compared with those in foreign countries. RESULTS: Sixty-two physicians and 114 warfarin users were recruited in the study. The average score of HK physicians in the knowledge of stroke prevention therapy in AF patients was lower than that of Australian (AUS) family physicians (HK 2.48 vs AUS 4.02 out of 7). The mean scores of AF patients in Hong Kong regarding the knowledge of AF were lower than that of United Kingdom (UK) (HK 1.16 vs UK 2.24 out of 4) (P < 0.001) and that of Finland (FIN) (HK 2.77 vs FIN 5.94 out of 8) (P < 0.001), respectively. The mean score of AF patients in Hong Kong regarding the knowledge of warfarin therapy was lower than that of AF patients in the United States (US) (HK 2.39 vs US 3.92). CONCLUSIONS: The barriers of warfarin use for AF patients in Hong Kong were related to both physicians and patients. Many Hong Kong physicians did not comply with international recommendations of stroke prevention in AF patients, and AF patients had a low knowledge level about the disease and warfarin therapy. Presented at the International Congress of Cardiology, Hong Kong, Peoples Republic of China, February 24-26, 2012. This study was supported by the School of Pharmacy, the Chinese University of Hong Kong. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
Authors:
Vivian W Y Lee; Cheuk Shing Tam; Bryan P Yan; Cheuk Man Yu; Yat Yin Lam
Related Documents :
17216996 - A prospective study: prediction of the first variceal haemorrhage in schistosomal and n...
23627576 - The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a...
9330496 - Demand for warfarin anticoagulation monitoring in tayside, scotland.
1899966 - Continuous infusion of monoclonal antibody-purified factor viii.
8322726 - The acrylic-splint herbst appliance: a cephalometric evaluation.
15146366 - Impact of disease activity on thyroid diseases in patients with acromegaly: basal evalu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-14
Journal Detail:
Title:  Clinical cardiology     Volume:  -     ISSN:  1932-8737     ISO Abbreviation:  Clin Cardiol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Wiley Periodicals, Inc.
Affiliation:
School of Pharmacy, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong. vivianlee@cuhk.edu.hk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interplay between vacuolar and siderophore-mediated iron storage in Aspergillus fumigatus.
Next Document:  Cardiopulmonary exercise test predicts sustained ventricular arrhythmias in chronic heart failure.